Cargando…

Barriers to Initiation of Pediatric HIV Treatment in Uganda: A Mixed-Method Study

Although the advantages of early infant HIV diagnosis and treatment initiation are well established, children often present late to HIV programs in resource-limited settings. We aimed to assess factors related to the timing of treatment initiation among HIV-infected children attending three clinical...

Descripción completa

Detalles Bibliográficos
Autores principales:	Boender, T. Sonia, Sigaloff, Kim C. E., Kayiwa, Joshua, Musiime, Victor, Calis, Job C. J., Hamers, Raph L., Nakatudde, Lillian Katumba, Khauda, Elizabeth, Mukuye, Andrew, Ditai, James, Geelen, Sibyl P., Mugyenyi, Peter, Rinke de Wit, Tobias F., Kityo, Cissy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3286886/ https://www.ncbi.nlm.nih.gov/pubmed/22400106 http://dx.doi.org/10.1155/2012/817506

Ejemplares similares

HIV Drug Resistance Among Children Initiating First-Line Antiretroviral Treatment in Uganda
por: Kityo, Cissy, et al.
Publicado: (2016)

Therapeutic drug monitoring of nevirapine in saliva in Uganda using high performance liquid chromatography and a low cost thin-layer chromatography technique
por: Lamorde, Mohammed, et al.
Publicado: (2014)

Pretreatment HIV drug resistance results in virological failure and accumulation of additional resistance mutations in Ugandan children
por: Kityo, Cissy, et al.
Publicado: (2017)

Long-Term Antiretroviral Treatment Adherence in HIV-Infected Adolescents and Adults in Uganda: A Qualitative Study
por: Inzaule, Seth C., et al.
Publicado: (2016)

Correction: Long-Term Antiretroviral Treatment Adherence in HIV-Infected Adolescents and Adults in Uganda: A Qualitative Study
por: Inzaule, Seth C., et al.
Publicado: (2017)

Previous antiretroviral drug use compromises standard first-line HIV therapy and is mediated through drug-resistance
por: Inzaule, Seth C., et al.
Publicado: (2018)

Multicentre analysis of second-line antiretroviral treatment in HIV-infected children: adolescents at high risk of failure
por: Boerma, Ragna S., et al.
Publicado: (2017)

Adherence to antiretroviral therapy for HIV in sub-Saharan Africa and Asia: a comparative analysis of two regional cohorts
por: Bijker, Rimke, et al.
Publicado: (2017)

Increasing the use of second-line therapy is a cost-effective approach to prevent the spread of drug-resistant HIV: a mathematical modelling study
por: Nichols, Brooke E, et al.
Publicado: (2014)

Identification of gaps for implementation science in the HIV prevention, care and treatment cascade; a qualitative study in 19 districts in Uganda
por: Bajunirwe, Francis, et al.
Publicado: (2016)

High levels of pre-treatment HIV drug resistance and treatment failure in Nigerian children
por: Boerma, Ragna S, et al.
Publicado: (2016)

Persistence of traditional and emergence of new structural drivers and factors for the HIV epidemic in rural Uganda; A qualitative study
por: Bajunirwe, Francis, et al.
Publicado: (2019)

Sequencing paediatric antiretroviral therapy in the context of a public health approach
por: Boerma, Ragna S, et al.
Publicado: (2015)

Plasma Biomarkers of Human Immunodeficiency Virus–Related Systemic Inflammation and Immune Activation in Sub-Saharan Africa Before and During Suppressive Antiretroviral Therapy
por: Kroeze, Stefanie, et al.
Publicado: (2019)

Clinical Evaluation of an Affordable Qualitative Viral Failure Assay for HIV Using Dried Blood Spots in Uganda
por: Balinda, Sheila N., et al.
Publicado: (2016)

Towards 90-90-90 Target: Factors Influencing Availability, Access, and Utilization of HIV Services—A Qualitative Study in 19 Ugandan Districts
por: Bajunirwe, Francis, et al.
Publicado: (2018)

Determinants of Clinician Knowledge on Aging and HIV/AIDS: A Survey of Practitioners and Policy Makers in Kampala District, Uganda
por: Obuku, Ekwaro A., et al.
Publicado: (2013)

Mortality in the Year Following Antiretroviral Therapy Initiation in HIV-Infected Adults and Children in Uganda and Zimbabwe
por: Walker, A. Sarah, et al.
Publicado: (2012)

The impact of HIV-1 subtypes on virologic and immunologic treatment outcomes at the Lagos University Teaching Hospital: A longitudinal evaluation
por: Ogbenna, Ann Abiola, et al.
Publicado: (2020)

A Randomized, Controlled, Trial of Short Cycle Intermittent Compared to Continuous Antiretroviral Therapy for the Treatment of HIV Infection in Uganda
por: Reynolds, Steven J., et al.
Publicado: (2010)

Clinical Differences between Younger and Older Adults with HIV/AIDS Starting Antiretroviral Therapy in Uganda and Zimbabwe: A Secondary Analysis of the DART Trial
por: Parikh, Sujal M., et al.
Publicado: (2013)

It is not always Tuberculosis! A case of pulmonary cryptococcosis in an immunocompetent child in Uganda
por: Nakatudde, Irene, et al.
Publicado: (2021)

Early mortality following ART initiation in HIV-infected adults and children in Uganda and Zimbabwe
por: Walker, AS, et al.
Publicado: (2010)

Circulating plasma NT-proBNP predicts subclinical coronary atherosclerosis on CT angiography among older adults in Uganda
por: Shakil, Saate S, et al.
Publicado: (2023)

Sex, HIV Status, and Measures of Cardiac Stress and Fibrosis in Uganda
por: Kipke, Jasmine, et al.
Publicado: (2021)

Cohort Profile: The PharmAccess African (PASER-M) and the TREAT Asia (TASER-M) Monitoring Studies to Evaluate Resistance—HIV drug resistance in sub-Saharan Africa and the Asia-Pacific
por: Hamers, Raph L, et al.
Publicado: (2012)

Vaccination timeliness and associated factors among preterm infants at a tertiary hospital in Uganda
por: Nakatudde, Irene, et al.
Publicado: (2019)

Sex-specific performance of the ASCVD pooled cohort equation risk calculator as a correlate of coronary artery calcium in Kampala, Uganda
por: Kentoffio, Katherine, et al.
Publicado: (2022)

Coronary artery calcium, HIV and inflammation in Uganda compared with the USA
por: Alencherry, Ben, et al.
Publicado: (2019)

Cost Effectiveness Analysis of Clinically Driven versus Routine Laboratory Monitoring of Antiretroviral Therapy in Uganda and Zimbabwe
por: Medina Lara, Antonieta, et al.
Publicado: (2012)

A Sex-Stratified Analysis of Monocyte Phenotypes Associated with HIV Infection in Uganda
por: Huaman, Moises A., et al.
Publicado: (2021)

Persistent immune activation and altered gut integrity over time in a longitudinal study of Ugandan youth with perinatally acquired HIV
por: Dirajlal-Fargo, Sahera, et al.
Publicado: (2023)

A Human-Centered Approach to CV Care: Infrastructure Development in Uganda
por: Longenecker, Christopher T., et al.
Publicado: (2018)

Exploring the barriers and facilitators to the acceptability of donor human milk in eastern Uganda – a qualitative study
por: Magowan, Sarah, et al.
Publicado: (2020)

Phylogeny of Yellow Fever Virus, Uganda, 2016
por: Hughes, Holly R., et al.
Publicado: (2018)

First-line HIV treatment failures in non-B subtypes and recombinants: a cross-sectional analysis of multiple populations in Uganda
por: Poon, Art F. Y., et al.
Publicado: (2019)

Population level usage of health services, and HIV testing and care, prior to decentralization of antiretroviral therapy in Agago District in rural Northern Uganda
por: Abongomera, G., et al.
Publicado: (2015)

Specialty career preferences among final year medical students at Makerere University College of health sciences, Uganda: a mixed methods study
por: Kuteesa, Job, et al.
Publicado: (2021)

Performance and Logistical Challenges of Alternative HIV-1 Virological Monitoring Options in a Clinical Setting of Harare, Zimbabwe
por: Ondoa, Pascale, et al.
Publicado: (2014)

A Single CD4 Test with 250 Cells/Mm(3) Threshold Predicts Viral Suppression in HIV-Infected Adults Failing First-Line Therapy by Clinical Criteria
por: Gilks, Charles F., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_04k0o1ktmij7rtmj9f805a1iuo